ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
PCV54 Cost-Effectiveness Analysis of Dabigatran Compared to Warfarin for Stroke Prevention in Atrial Fibrillation in a Medicare Population
Value in Health
◽
10.1016/j.jval.2012.03.657
◽
2012
◽
Vol 15
(4)
◽
pp. A121
Author(s):
M.A. Ward
◽
A.K. Biddle
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Cost Effectiveness Analysis
◽
Medicare Population
◽
Effectiveness Analysis
Download Full-text
Related Documents
Cited By
References
Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries
Current Medical Research and Opinion
◽
10.1080/03007995.2017.1375470
◽
2017
◽
Vol 34
(1)
◽
pp. 55-63
◽
Cited By ~ 3
Author(s):
Siyang Peng
◽
Kristen A. Deger
◽
Anastasia Ustyugova
◽
Pranav Gandhi
◽
Nan Qiao
◽
...
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Real World
◽
Stroke Prevention
◽
Cost Effectiveness Analysis
◽
Medicare Beneficiaries
◽
Effectiveness Analysis
◽
Real World Evidence
Download Full-text
Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding
PharmacoEconomics
◽
10.1007/s40273-018-0741-3
◽
2018
◽
Vol 37
(2)
◽
pp. 279-289
◽
Cited By ~ 4
Author(s):
Thananan Rattanachotphanit
◽
Chulaporn Limwattananon
◽
Onanong Waleekhachonloet
◽
Phumtham Limwattananon
◽
Kittisak Sawanyawisuth
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
High Risk
◽
Stroke Prevention
◽
Oral Anticoagulants
◽
Cost Effectiveness Analysis
◽
Risk Of Bleeding
◽
Effectiveness Analysis
◽
Direct Acting
◽
Direct Acting Oral Anticoagulants
Download Full-text
PCV50 COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
Value in Health
◽
10.1016/j.jval.2011.02.237
◽
2011
◽
Vol 14
(3)
◽
pp. A41
Author(s):
Y. Zhao
◽
L. Lim
◽
C.I. Coleman
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Dose Warfarin
◽
Adjusted Dose
Download Full-text
PCV84 - COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION SPANISH PATIENTS
Value in Health
◽
10.1016/j.jval.2018.09.630
◽
2018
◽
Vol 21
◽
pp. S106
Author(s):
F. de Andrés-Nogales
◽
I. Oyagüez
◽
C. Suarez
◽
J.L. Lopez-Sendon
◽
J.R. Gonzalez-Juanatey
◽
...
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS
Value in Health
◽
10.1016/j.jval.2019.09.774
◽
2019
◽
Vol 22
◽
pp. S549-S550
Author(s):
F. de Andrés-Nogales
◽
P.R. Gay-Pobes
◽
M. Inês
◽
C. Polanco Sánchez
◽
D. Alves
◽
...
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation
BMC Cardiovascular Disorders
◽
10.1186/s12872-016-0351-y
◽
2016
◽
Vol 16
(1)
◽
Cited By ~ 3
Author(s):
Vivian Wing-Yan Lee
◽
Ronald Bing-Ching Tsai
◽
Ines Hang-Iao Chow
◽
Bryan Ping-Yen Yan
◽
Mehmet Gungor Kaya
◽
...
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Left Atrial
◽
Left Atrial Appendage
◽
Cost Effectiveness Analysis
◽
Atrial Appendage
◽
Left Atrial Appendage Occlusion
◽
Effectiveness Analysis
Download Full-text
Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting
INDONESIAN JOURNAL OF PHARMACY
◽
10.14499/indonesianjpharm30iss1pp74
◽
2019
◽
Vol 30
(1)
◽
pp. 74
Author(s):
Iwan Dwiprahasto
◽
Erna Kristin
◽
Dwi Endarti
◽
Rizaldy Taslim Pinzon
◽
Alfi Yasmina
◽
...
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Healthcare Setting
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
Clinical Drug Investigation
◽
10.1007/s40261-013-0144-3
◽
2013
◽
Vol 34
(1)
◽
pp. 9-17
◽
Cited By ~ 35
Author(s):
Carla Rognoni
◽
Monia Marchetti
◽
Silvana Quaglini
◽
Nicola Lucio Liberato
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
WITHDRAWN: Cost-effectiveness analysis of left atrial appendage occlusion compared with seven pharmacological strategies for stroke prevention in atrial fibrillation
Clinical Trials and Regulatory Science in Cardiology
◽
10.1016/j.ctrsc.2015.08.005
◽
2015
◽
Author(s):
Vivian Wing-Yan Lee
◽
Ronald Bing-Ching Tsai
◽
Ines Hang-Iao Chow
◽
Bryan Ping-Yen Yan
◽
Mehmet Gungor Kaya
◽
...
Keyword(s):
Atrial Fibrillation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Left Atrial
◽
Left Atrial Appendage
◽
Cost Effectiveness Analysis
◽
Atrial Appendage
◽
Left Atrial Appendage Occlusion
◽
Effectiveness Analysis
Download Full-text
PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Greece: A Cost –Effectiveness Analysis under the Greek NHS Setting
Value in Health
◽
10.1016/j.jval.2011.08.797
◽
2011
◽
Vol 14
(7)
◽
pp. A378
Author(s):
V. Fragoulakis
◽
T. Theodoratou
◽
N. Maniadakis
Keyword(s):
Atrial Fibrillation
◽
Economic Evaluation
◽
Cost Effectiveness
◽
Stroke Prevention
◽
Dabigatran Etexilate
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close